These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38781924)

  • 1. Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
    Chang T; Cho SI; Yoo DS; Min KD
    Emerg Infect Dis; 2024 Jun; 30(6):1154-1163. PubMed ID: 38781924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of non-pharmaceutical interventions for COVID-19 on other nationally notifiable infectious diseases in South Korea.
    Lee HJ; Hwang BS; Im SH; Mun SK; Chang M
    Korean J Intern Med; 2024 Sep; 39(5):823-832. PubMed ID: 39135523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
    Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
    Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 Pandemic on the Incidence of Notifiable Infectious Diseases in China Based on SARIMA Models Between 2013 and 2021.
    Liu J; Zeng W; Zhuo C; Liu Y; Zhu L; Zou G
    J Epidemiol Glob Health; 2024 Sep; 14(3):1191-1201. PubMed ID: 39080246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of COVID-19 on Tuberculosis Notification, South Korea.
    Kwak N; Hwang SS; Yim JJ
    Emerg Infect Dis; 2020 Oct; 26(10):2506-2508. PubMed ID: 32672531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.
    Yum S; Hong K; Sohn S; Kim J; Chun BC
    Emerg Infect Dis; 2021; 27(6):1685-1688. PubMed ID: 34013875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.
    Huh K; Jung J; Hong J; Kim M; Ahn JG; Kim JH; Kang JM
    Clin Infect Dis; 2021 Apr; 72(7):e184-e191. PubMed ID: 33150393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COVID-19 epidemic and other notifiable infectious diseases in China.
    Bai BK; Jiang QY; Hou J
    Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifting COVID-19-associated non-pharmaceutical interventions: potential impact on notifications of infectious diseases transmitted from person to person in 2022 in Bavaria, Germany.
    Hausmann J; Dörre A; Katz K; van de Berg S
    Front Public Health; 2024; 12():1437485. PubMed ID: 39148653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States.
    Kim S; Kim J; Choi BY; Park B
    Epidemiol Health; 2022; 44():e2022011. PubMed ID: 34990526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
    Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea.
    Kim DH; Nguyen TM; Kim JH
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34205018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinovirus Incidence Rates Indicate We Are Tired of Non-pharmacological Interventions Against Coronavirus Disease 2019.
    Kim MC; Park JH; Choi SH; Chung JW
    J Korean Med Sci; 2022 Jan; 37(2):e15. PubMed ID: 35014227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Medical Use of Military Hospitals in Korea.
    Yoon D; Kim KE; Lee JE; Kim M; Kim JH
    J Korean Med Sci; 2021 Jul; 36(28):e204. PubMed ID: 34282607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 20. A Silver Lining? Fewer Non-Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic.
    Most ZM; Holcomb M; Jamieson AR; Perl TM
    J Infect Dis; 2021 Nov; 224(10):1751-1755. PubMed ID: 33830238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.